Michael W. Handlogten

Harnessing structure-activity relationship to engineer a cisplatin nanoparticle for enhanced antitumor efficacy

Abhimanyu S. Paraskar, Shivani Soni, Kenneth T. Chin et al. · Proceedings of the National Academy of Sciences · 2010 · 130 citations · Full text

Intracellular response to process optimization and impact on productivity and product aggregates for a high‐titer CHO cell process

Michael W. Handlogten, Allison Lee‐O'Brien, Gargi Roy et al. · Biotechnology and Bioengineering · 2017 · 89 citations

Effects of antibody disulfide bond reduction on purification process performance and final drug substance stability

Wai Keen Chung, Brian Russell, Yanhong Yang et al. · Biotechnology and Bioengineering · 2017 · 55 citations · Full text

Small-Molecule-Based Affinity Chromatography Method for Antibody Purification via Nucleotide Binding Site Targeting

Nathan J. Alves, Samuel D. Stimple, Michael W. Handlogten et al. · Analytical Chemistry · 2012 · 46 citations

Complex Mixtures, Immunology, Molecular Biology +23

Inhibition of weak-affinity epitope-IgE interactions prevents mast cell degranulation

Michael W. Handlogten, Tanyel Kiziltepe, Ana Serezani et al. · Nature Chemical Biology · 2013 · 36 citations · Full text

Allergy, Mast Cell Disorder, Immunology +6